Chiral Quest, a Subsidiary of VioQuest Pharmaceuticals, to Host First Annual Process Research Technology Conference
08. März 2006 09:33 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., March 8, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) subsidiary Chiral Quest is hosting the first annual Process Research Technology Conference, an...
VioQuest Pharmaceuticals Named One of Deloitte's 500 Fastest Growing North American Technology Companies
15. Februar 2006 08:30 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Feb. 15, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) was named among the "2005 Deloitte Technology Fast 500," a collection of the 500 fastest growing...
VioQuest's Targeted Cancer Therapeutics Featured in 'Healthwatch' On New Jersey Public Television and Other Television Stations Across the Country
23. Januar 2006 09:25 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Jan. 23, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing targeted...
VioQuest Pharmaceuticals Highlights 2005 Achievements
10. Januar 2006 08:00 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Jan. 10, 2006 (PRIMEZONE) -- During 2005 VioQuest Pharmaceuticals (OTCBB:VQPH) made significant progress on its business strategy and achieved several important...
VioQuest Pharmaceuticals Announces Clinical Trials to Begin in First Quarter 2006 for VQD-002, a Targeted Akt/Anti-Cancer Therapeutic
09. Januar 2006 08:30 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Jan. 9, 2006 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH) has announced that it will initiate clinical trials in the first quarter 2006, for VQD-002,...
VioQuest Pharmaceuticals to Receive Approximately $500,000 of Non-Dilutive Funds through Agreement with New Jersey Economic Development Authority
13. Dezember 2005 08:00 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Dec. 13, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals (OTCBB:VQPH) will receive approximately $500,000 from the sale of its Net Operating Losses (NOLs) pursuant to an...
VioQuest Appoints Dr. Johnson Lau to Board of Directors
02. Dezember 2005 08:32 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Dec. 2, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc., (OTCBB:VQPH) has named Johnson Y.N. Lau, M.B., B.S., M.D., F.R.C.P., to the Company's Board of Directors.
Dr....
VioQuest Pharmaceuticals to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
02. November 2005 08:00 ET
|
VioQuest Pharmaceuticals
MONMOUTH, N.J., Nov. 2, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc., (OTCBB:VQPH) has accepted an invitation to present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference at...
VioQuest Pharmaceuticals to Present at 2005 Medical Innovation Summit Hosted by Cleveland Clinic
24. Oktober 2005 08:00 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Oct. 24, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) has accepted an invitation to present at the 2005 Medical Innovation Summit: Bench to Bedside and...
VioQuest Pharmaceuticals to Present at PIPEs Conference 2005 in New York City
21. Oktober 2005 08:00 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Oct. 21, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) has accepted an invitation to present at the 3rd Annual PIPEs Conference 2005 on October 26 and 27 at...